High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia
Open Access
- 1 February 1998
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 9 (2) , 159-165
- https://doi.org/10.1023/a:1008255511404
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Quantitation of resistance to cytosine arabinoside by myeloid leukemic cells expressing bcl-2European Journal of Haematology, 1996
- Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation StudyBlood, 1996
- Biological Features of Leukaemic Cells Associated with Autonomous Growth and Reduced Survival in Acute Myeloblastic LeukaemiaLeukemia & Lymphoma, 1995
- High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cellsBlood, 1993
- Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemiaBlood, 1993
- High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapyBlood, 1993
- Autonomous Proliferation of Leukemic Cells in Vitro as a Determinant of Prognosis in Adult Acute Myeloid LeukemiaNew England Journal of Medicine, 1993
- Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell lineBlood, 1993
- bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cellsBlood, 1992
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990